Keyphrases
Acute Lymphoblastic Leukemia
19%
Adult Cancer
16%
Allopurinol
16%
Assessment Intervention
16%
Cancer-related Symptoms
19%
Cause of Death
16%
Central Nervous System
16%
Chemosensitivity
19%
Childhood Acute Lymphoblastic Leukemia
21%
Childhood Cancer Survivors
49%
Chronic Pain
32%
Community Gardens
16%
Dietary Intervention
16%
Educational Needs
16%
Gardeners
16%
Gardening Intervention
16%
Glucocorticoid Resistance
16%
Health Screening
16%
Hematopoietic Stem Cell Transplant
22%
Increased Safety
16%
Infant Acute Lymphoblastic Leukemia
16%
Maintenance Therapy
16%
Mercaptopurine
16%
NT5C2
16%
Nutritional Assessment
16%
Occupational Aspirations
16%
Older Adults
16%
Pain in children
19%
Pain Management
19%
Parotid Gland Enlargement
16%
Pediatric Acute Lymphoblastic Leukemia
38%
Pediatric Leukemia
32%
Pediatric Oncology
25%
Pediatric Patients
16%
Physical Activity
25%
Physical Activity Intervention
36%
Physical Activity Program
16%
Physical Fitness Index
16%
Physical Support
16%
Pilot Randomized Controlled Trial
32%
Poorly Differentiated Neuroendocrine Carcinoma
16%
Psychological Support
16%
Resistance Mechanisms
16%
Scoping Review
32%
Single Center
16%
Single Institution
16%
Standardized Mortality Ratio
16%
Successful Treatment
16%
Survivors
46%
Survivorship
32%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
62%
Analgesia
18%
BRCA2
5%
Cancer in Young Adults
49%
Cancer Therapy
7%
Catenin
8%
Central Nervous System
16%
Chemosensitivity
19%
Childhood Cancer
58%
Chronic Pain
32%
Clofarabine
9%
Diet Therapy
16%
Diseases
8%
Exercise
12%
Exercise Test
7%
Exome Sequencing
5%
Fertility Preservation
16%
Germinoma
6%
Glucocorticoid
16%
Health Care Cost
8%
Health Outcomes
6%
Heart Disease
5%
Hematopoietic Stem Cell Transplantation
22%
Intrathecal Drug Administration
6%
Kinase Signaling
16%
Leukemia
23%
Leukemia Cell Line
6%
Long QT Syndrome
16%
Malignant Neoplasm
78%
Mass Screening
16%
Mitogen-Activated Protein Kinase
16%
Myeloid Sarcoma
16%
Neuroendocrine Carcinoma
16%
Nutrition Assessment
16%
Parotid Gland
16%
Pediatric Acute Myeloid Leukemia
16%
Pediatrics
49%
Pediatrics Patient
16%
Physical Activity
81%
Prednisolone
15%
Primary Tumor
10%
Randomized Controlled Trial
34%
Standardized Mortality Ratio
16%
Supportive Care
8%
Systematic Review
16%
Thiotepa
9%
Topotecan
9%
Vinorelbine
9%
Wnt Signaling
8%
